Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $530,499 - $651,036
22,700 Added 630.56%
26,300 $729,000
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $84,227 - $99,107
3,100 Added 620.0%
3,600 $100,000
Q2 2023

Aug 14, 2023

SELL
$28.34 - $33.63 $59,514 - $70,623
-2,100 Reduced 80.77%
500 $15,000
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $57,044 - $68,224
2,600 New
2,600 $67,000
Q2 2022

Aug 08, 2022

BUY
$26.4 - $30.54 $1.96 Million - $2.27 Million
74,200 Added 37100.0%
74,400 $2.22 Million
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $96,894 - $117,558
-4,200 Reduced 95.45%
200 $5,000
Q4 2021

Feb 14, 2022

SELL
$21.47 - $32.08 $15,029 - $22,456
-700 Reduced 13.73%
4,400 $102,000
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $119,187 - $163,863
5,100 New
5,100 $157,000
Q1 2021

May 17, 2021

SELL
$18.21 - $23.2 $449,787 - $573,040
-24,700 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$15.39 - $22.1 $341,658 - $490,620
22,200 Added 888.0%
24,700 $493,000
Q3 2020

Nov 16, 2020

SELL
$16.16 - $20.66 $85,648 - $109,498
-5,300 Reduced 67.95%
2,500 $41,000
Q2 2020

Aug 14, 2020

SELL
$13.31 - $19.41 $1 Million - $1.47 Million
-75,500 Reduced 90.64%
7,800 $151,000
Q1 2020

May 15, 2020

BUY
$13.06 - $21.24 $1 Million - $1.63 Million
76,600 Added 1143.28%
83,300 $1.2 Million
Q4 2019

Feb 14, 2020

BUY
$17.29 - $21.74 $98,553 - $123,917
5,700 Added 570.0%
6,700 $137,000
Q3 2019

Nov 14, 2019

SELL
$19.51 - $24.28 $46,824 - $58,272
-2,400 Reduced 70.59%
1,000 $20,000
Q2 2019

Aug 14, 2019

SELL
$21.47 - $37.33 $36,499 - $63,461
-1,700 Reduced 33.33%
3,400 $77,000
Q1 2019

May 15, 2019

SELL
$28.4 - $36.49 $107,920 - $138,662
-3,800 Reduced 42.7%
5,100 $186,000
Q4 2018

Feb 14, 2019

BUY
$27.94 - $44.61 $184,404 - $294,426
6,600 Added 286.96%
8,900 $263,000
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $93,288 - $118,128
2,300 New
2,300 $95,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.